Shanghai Kaibao Pharmaceutical (300039) — Cash Flow Reinvestment Rate
Shanghai Kaibao Pharmaceutical (300039) has a Cash Flow Reinvestment Rate of 0.02x as of September 2025, reinvesting CN¥3.37 Million (capex CN¥3.37 Million ) from operating cash flow of CN¥190.98 Million. Explore capital reinvestment ratio of Shanghai Kaibao Pharmaceutical to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Kaibao Pharmaceutical Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Shanghai Kaibao Pharmaceutical across 19 annual periods. Also explore balance sheet size of Shanghai Kaibao Pharmaceutical for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year capital reinvestment analysis for Shanghai Kaibao Pharmaceutical. For live market cap and broader valuation context, see market value of Shanghai Kaibao Pharmaceutical.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.52x | CN¥145.48 Million | CN¥278.95 Million | CN¥140.52 Million | ▼ -12.4% |
| 2023 | 0.60x | CN¥227.71 Million | CN¥382.66 Million | CN¥29.08 Million | ▼ -29.3% |
| 2022 | 0.84x | CN¥316.99 Million | CN¥376.42 Million | CN¥31.62 Million | ▲ +46.5% |
| 2021 | 0.57x | CN¥72.48 Million | CN¥126.08 Million | CN¥42.55 Million | ▲ +73.0% |
| 2020 | 0.33x | CN¥83.28 Million | CN¥250.65 Million | CN¥13.94 Million | ▼ -82.2% |
| 2019 | 1.86x | CN¥622.91 Million | CN¥334.09 Million | CN¥15.46 Million | ▲ +155.3% |
| 2018 | 0.73x | CN¥191.63 Million | CN¥262.36 Million | CN¥26.07 Million | ▼ -25.3% |
| 2017 | 0.98x | CN¥240.28 Million | CN¥245.76 Million | CN¥49.24 Million | ▼ -29.5% |
| 2016 | 1.39x | CN¥436.47 Million | CN¥314.88 Million | CN¥27.03 Million | ▲ +330.4% |
| 2015 | 0.32x | CN¥105.34 Million | CN¥327.08 Million | CN¥50.40 Million | ▲ +32.3% |
| 2014 | 0.24x | CN¥68.74 Million | CN¥282.38 Million | CN¥68.74 Million | ▼ -44.4% |
| 2013 | 0.44x | CN¥118.28 Million | CN¥270.23 Million | CN¥118.28 Million | ▲ +104.0% |
| 2012 | 0.21x | CN¥52.21 Million | CN¥243.32 Million | CN¥52.21 Million | ▼ -69.4% |
| 2011 | 0.70x | CN¥68.85 Million | CN¥98.31 Million | CN¥68.85 Million | ▼ -72.8% |
| 2010 | 2.58x | CN¥51.01 Million | CN¥19.79 Million | CN¥51.01 Million | ▲ +8.1% |
| 2009 | 2.38x | CN¥125.70 Million | CN¥52.74 Million | CN¥125.70 Million | ▲ +294.9% |
| 2008 | 0.60x | CN¥11.28 Million | CN¥18.70 Million | CN¥11.28 Million | ▲ +204.1% |
| 2007 | 0.20x | CN¥4.62 Million | CN¥23.27 Million | CN¥4.62 Million | ▼ -66.7% |
| 2006 | 0.60x | CN¥11.74 Million | CN¥19.70 Million | CN¥11.74 Million | — |